HealthEquity, Inc.
HQYNASDAQHealthcare● Active
$87.96
$-0.71(-0.80%)
Market Cap$7.4B
P/E Ratio—
52W High$116.65
52W Low$72.76
HealthEquity, Inc. (HQY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
HQY · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 28, 2026EPS Actual
$1.24
Est. $1.11 · +11.7%
Revenue
$0.35B
Est. $0.35B · +0.8%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 28, 2026
After Market Close
▲ Beat EPS🔥 5-Quarter EPS Beat Streak
HQY reports quarterly as a NASDAQ-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 1, 2026 | $1.19 | — | — | — | $0.35B | — |
| ▲ Q2 FY2026 | May 28, 2026 | $1.11 | $1.24 | +11.7% | $0.35B | $0.35B | +0.8% |
| ▲ Q1 FY2026 | Mar 17, 2026 | $0.89 | $0.95 | +6.7% | $0.33B | $0.33B | +0.7% |
| ▲ Q4 FY2025 | Dec 3, 2025 | $0.91 | $1.01 | +10.8% | $0.32B | $0.32B | +0.5% |
| ▲ Q3 FY2025 | Sep 2, 2025 | $0.91 | $1.08 | +18.2% | $0.33B | $0.32B | +1.6% |
| ▲ Q2 FY2025 | Jun 3, 2025 | $0.81 | $0.97 | +19.3% | $0.33B | $0.32B | +2.7% |
| ▼ Q1 FY2025 | Mar 18, 2025 | $0.71 | $0.69 | -2.8% | $0.31B | $0.31B | +2.0% |
| ▲ Q4 FY2024 | Dec 9, 2024 | $0.71 | $0.78 | +9.9% | $0.30B | $0.29B | +3.6% |
Q3 FY2026
Sep 1, 2026
EPS Actual
—
EPS Est.
$1.19
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 28, 2026Beat
EPS Actual
$1.24
EPS Est.
$1.11
EPS Surpr.
+11.7%
Revenue
$0.35B
Q1 FY2026
Mar 17, 2026Beat
EPS Actual
$0.95
EPS Est.
$0.89
EPS Surpr.
+6.7%
Revenue
$0.33B
Q4 FY2025
Dec 3, 2025Beat
EPS Actual
$1.01
EPS Est.
$0.91
EPS Surpr.
+10.8%
Revenue
$0.32B
Q3 FY2025
Sep 2, 2025Beat
EPS Actual
$1.08
EPS Est.
$0.91
EPS Surpr.
+18.2%
Revenue
$0.33B
Q2 FY2025
Jun 3, 2025Beat
EPS Actual
$0.97
EPS Est.
$0.81
EPS Surpr.
+19.3%
Revenue
$0.33B
Q1 FY2025
Mar 18, 2025Miss
EPS Actual
$0.69
EPS Est.
$0.71
EPS Surpr.
-2.8%
Revenue
$0.31B
Q4 FY2024
Dec 9, 2024Beat
EPS Actual
$0.78
EPS Est.
$0.71
EPS Surpr.
+9.9%
Revenue
$0.30B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $1.32 | $1.34 | $1.35 | 5 |
| Q4 FY2027 | $1.32 | $1.34 | $1.35 | 4 |
| Q3 FY2027 | $1.36 | $1.38 | $1.39 | 4 |
| Q2 FY2027 | $1.39 | $1.41 | $1.42 | 4 |
| Q1 FY2027 | $1.13 | $1.14 | $1.15 | 4 |
| Q4 FY2026 | $1.12 | $1.16 | $1.21 | 10 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $0.4B | $0.4B | $0.4B | 4 |
| Q4 FY2027 | $0.4B | $0.4B | $0.4B | 5 |
| Q3 FY2027 | $0.4B | $0.4B | $0.4B | 5 |
| Q2 FY2027 | $0.4B | $0.4B | $0.4B | 5 |
| Q1 FY2027 | $0.4B | $0.4B | $0.4B | 5 |
| Q4 FY2026 | $0.3B | $0.3B | $0.3B | 10 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 28, 2026 | +11.7% | $86.56 | $90.52 | +4.57% |
| ▲ Q1 FY2026 | Mar 17, 2026 | +6.7% | $78.67 | $79.40 | +0.93% |
| ▲ Q4 FY2025 | Dec 3, 2025 | +10.8% | $98.88 | $98.64 | -0.24% |
| ▲ Q3 FY2025 | Sep 2, 2025 | +18.2% | $89.33 | $88.85 | -0.54% |
| ▲ Q2 FY2025 | Jun 3, 2025 | +19.3% | $102.81 | $103.76 | +0.92% |
| ▼ Q1 FY2025 | Mar 18, 2025 | -2.8% | $100.72 | $101.67 | +0.94% |
| ▲ Q4 FY2024 | Dec 9, 2024 | +9.9% | $100.21 | $101.00 | +0.79% |
| ▲ Q3 FY2024 | Sep 3, 2024 | +23.0% | No price data | $78.63 | — |
Q2 FY2026+4.57%
Report Date
May 28, 2026
EPS Beat/Miss
+11.7%
Price Before
$86.56
Price After
$90.52
Q1 FY2026+0.93%
Report Date
Mar 17, 2026
EPS Beat/Miss
+6.7%
Price Before
$78.67
Price After
$79.40
Q4 FY2025-0.24%
Report Date
Dec 3, 2025
EPS Beat/Miss
+10.8%
Price Before
$98.88
Price After
$98.64
Q3 FY2025-0.54%
Report Date
Sep 2, 2025
EPS Beat/Miss
+18.2%
Price Before
$89.33
Price After
$88.85
Q2 FY2025+0.92%
Report Date
Jun 3, 2025
EPS Beat/Miss
+19.3%
Price Before
$102.81
Price After
$103.76
Q1 FY2025+0.94%
Report Date
Mar 18, 2025
EPS Beat/Miss
-2.8%
Price Before
$100.72
Price After
$101.67
Q4 FY2024+0.79%
Report Date
Dec 9, 2024
EPS Beat/Miss
+9.9%
Price Before
$100.21
Price After
$101.00
Q3 FY2024—
Report Date
Sep 3, 2024
EPS Beat/Miss
+23.0%
Price Before
—
Price After
$78.63
Avg Beat Reaction+1.07%
Avg Miss Reaction+0.94%
Beat Rate7 / 8 quarters
Largest Move+4.57% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: HQY ends December
HealthEquity, Inc. (HQY) most recently reported earnings on May 28, 2026 for Q2 FY2026, posting EPS of $1.24 — beating the analyst consensus of $1.11 by +11.7%. HQY has beaten EPS estimates for 5 consecutive quarters. The next HQY earnings date is expected around September 1, 2026.
Each quarter, investors track HQY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. HQY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
HQY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
HQY earnings · 5 questionsHealthEquity, Inc.'s next earnings report is expected around September 1, 2026. HQY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; HQY historically reports after market close (AMC).
HQY earnings datewhen is HQY earningsHQY next earnings datewhen does HQY report earningsHQY earnings calendar
▸ Source: FMP · HealthEquity, Inc. SEC filings · US GAAP · HealthEquity, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026